SOURCE: ZELTIQ Aesthetics, Inc.

May 27, 2014 16:05 ET

ZELTIQ to Participate at Investor Conferences in June 2014

PLEASANTON, CA--(Marketwired - May 27, 2014) - ZELTIQ® (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, and Patrick F. Williams, Senior Vice President and Chief Financial Officer, are scheduled to participate in various investor conferences in June 2014.

Event: Jefferies 2014 Global Healthcare Conference
Format: One-on-One Meetings Only
Date:
June 2, 2014
Time: TBD

Event: William Blair & Company 34th Annual Growth Stock Conference
Format: Presentation and One-on-One Meetings
Date:
June 10, 2014
Time: 12:10 p.m. CT / 1:10 p.m. ET

Event: Goldman Sachs 35th Annual Global Healthcare Conference 
Format: Presentation and One-on-One Meetings
Date:
June 11, 2014
Time: 10:00 a.m. PT / 1:00 p.m. ET

An audio webcast of the Company's presentation will be available by visiting the investor relations section of ZELTIQ's web site at www.coolsculpting.com. A replay of the presentation will be available for 90 days.

About ZELTIQ® Aesthetics
ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform. ZELTIQ's first commercial product, the CoolSculpting® System, is designed to selectively reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.